{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:21:56Z","timestamp":1787502116689,"version":"build-2736575974"},"reference-count":133,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) continues to cause substantial morbidity and mortality. Most infections are mild; however, some patients experience severe and potentially fatal systemic inflammation, tissue damage, cytokine storm, and acute respiratory distress syndrome. Patients with chronic liver disease have been frequently affected, experiencing high morbidity and mortality. In addition, elevated liver enzymes may be a risk factor for disease progression, even in the absence of underlying liver disease. While the respiratory tract is a primary target of SARS-CoV-2, it has become evident that COVID-19 is a multisystemic infectious disease. The hepatobiliary system might be influenced during COVID-19 infection, ranging from a mild elevation of aminotransferases to the development of autoimmune hepatitis and secondary sclerosing cholangitis. Furthermore, the virus can promote existing chronic liver diseases to liver failure and activate the autoimmune liver disease. Whether the direct cytopathic effects of the virus, host reaction, hypoxia, drugs, vaccination, or all these risk factors cause liver injury has not been clarified to a large extent in COVID-19. This review article discussed the molecular and cellular mechanisms involved in the pathogenesis of SARS-CoV-2 virus-associated liver injury and highlighted the emerging role of liver sinusoidal epithelial cells (LSECs) in virus-related liver damage.<\/jats:p>","DOI":"10.3390\/v15061287","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T02:01:15Z","timestamp":1685498475000},"page":"1287","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury"],"prefix":"10.3390","volume":"15","author":[{"given":"Hikmet","family":"Akkiz","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Medical Faculty, Bah\u00e7e\u015fehir University, Istanbul 34349, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","article-title":"Innate immunity: The first line defense against SARS-CoV-2","volume":"23","author":"Diamond","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The \u201ccytokine Storm\u201d: Molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Booth, A., Reed, A.B., Ponzo, S., Yassaee, A., Aral, M., Plans, D., and Mohan, D. (2021). Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0247461"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases 0f 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with Novel Coronavirus-infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref_8","first-page":"636532","article-title":"Implications of the Novel Mutations in the SARS-CoV-2 Genome for Transmission, Disease Severity, and the Vaccine Development","volume":"6","year":"2021","journal-title":"Front. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: An overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Anderson","year":"2020","journal-title":"Nat. Med."},{"key":"ref_12","first-page":"55","article-title":"Coronavirus biology and replication: Implications for SARS-CoV-2","volume":"19","author":"Kratzel","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"849217","DOI":"10.3389\/fmed.2022.849217","article-title":"The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Concern","volume":"9","year":"2022","journal-title":"Front. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: Evidencee that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"1126","author":"Lamers","year":"2020","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Brandi, N., Ciccorese, F., Rimondi, M.R., Balacchi, C., Modolon, C., Sportoletti, C., Renzulli, M., Coppola, F., and Golfieri, R. (2022). An Imaging Overview of COVID-19 ARDS in ICU Patients and Its Complications: A Pictorial Review. Diagnostics, 12.","DOI":"10.3390\/diagnostics12040846"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/apm.13210","article-title":"Could SARS-CoV-2 infection affect male fertility and sexuality?","volume":"130","author":"Muti","year":"2022","journal-title":"APMIS"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12072-020-10071-9","article-title":"Coronavirus disease 19 (COVID-19) and the Liver: A comprehensive systematic review and meta-analysis","volume":"14","author":"Kumar","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jhep.2022.07.008","article-title":"Impact of COVID-19 on the liver and the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper","volume":"77","author":"Marjot","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00535-021-01760-9","article-title":"COVID-19-associated liver injury: From bedside to bench","volume":"56","author":"Li","year":"2021","journal-title":"J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3748\/wjg.v28.i15.1526","article-title":"COVID-19 and liver dysfunction: What nutritionists need to know","volume":"28","author":"Wang","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/liv.14470","article-title":"COVID-19 and liver disease","volume":"40","author":"Sun","year":"2020","journal-title":"Liver Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.31684","article-title":"Liver Disease and Coronavirus Disease 2019, from Pathogenesis to Clinical Care","volume":"74","author":"Saviano","year":"2021","journal-title":"Hepatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s12072-022-10364-1","article-title":"SARS-CoV-2 infection and liver involvement","volume":"16","author":"Luo","year":"2022","journal-title":"Hepatol. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/hep.31472","article-title":"Elevated Liver Biochemistries in Hospitalized Chinese Patients with Sever COVID-19: Systemic Review and Meta-analysis","volume":"73","author":"Kovalic","year":"2021","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-020-00243-2","article-title":"COVID-19: Immunopathogenesis and immunotherapeutics","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_29","first-page":"1170","article-title":"Role of the humoral immune response during COVID-19: Guilty or not guilty","volume":"15","author":"Bourlet","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12912","article-title":"Intracellular innate immune receptors: Life inside the cell","volume":"297","author":"Kanneganti","year":"2020","journal-title":"Immunol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.celrep.2020.108185","article-title":"SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant","volume":"32","author":"Konno","year":"2020","journal-title":"Cell Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"198074","DOI":"10.1016\/j.virusres.2020.198074","article-title":"The ORF6, ORF8, and nucleocapsid proteins of SARS-CoV-2 inhibit the type 2 interferon signaling pathway","volume":"286","author":"Li","year":"2020","journal-title":"Virus Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives the development of COVID-19","volume":"181","author":"Liu","year":"2020","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S2213-2600(20)30354-4","article-title":"SARS-CoV-2 viral load predicts COVID-19 mortality","volume":"8","author":"Pujadas","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type 1 interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hep.31446","article-title":"Clinical Features of Patients Infected with Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study","volume":"73","author":"Fu","year":"2021","journal-title":"Hepatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.31404","article-title":"Acute liver injury in COVID-19: Prevalence Association with Clinical Outcomes in a large, U.S. Cohort","volume":"72","author":"Phipps","year":"2020","journal-title":"Hepatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2020.06.006","article-title":"COVID-19 and liver","volume":"73","author":"Jathimoni","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.32668","article-title":"COVID-19-associated c3holangiopathy: What is left after the virus has gone?","volume":"76","author":"Heucke","year":"2022","journal-title":"Hepatology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/2050640620931657","article-title":"Patterns of liver injury\u2014A German case series","volume":"8","author":"Schattenberg","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11739-020-02425-w","article-title":"Impact of COVID-19 on liver function: Results from an internal medicine unit in Northern Italy","volume":"15","author":"Lenti","year":"2020","journal-title":"Intern. Emerg. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/liv.14465","article-title":"Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis","volume":"40","author":"Mantovani","year":"2020","journal-title":"Liver Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.32582","article-title":"Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease","volume":"76","author":"Hartl","year":"2022","journal-title":"Hepatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","article-title":"COVID-19: Abnormal liver function tests","volume":"73","author":"Cai","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_45","first-page":"326792","article-title":"COVID-19, and liver disease","volume":"71","author":"Dufour","year":"2021","journal-title":"Gut"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s13238-020-00718-6","article-title":"Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids","volume":"11","author":"Zhao","year":"2020","journal-title":"Protein Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1038\/s41598-022-09306-6","article-title":"Human liver organoid-derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication","volume":"12","author":"Lui","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/liv.14730","article-title":"Pathophysiological mechanisms of liver injury in COVID-19","volume":"41","author":"Nardo","year":"2021","journal-title":"Liver Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/cid\/ciab686","article-title":"Severe acute respiratory syndrome coronavirus 2 viremias are associated with coronavirus disease 2019 severity and predict clinical outcomes","volume":"74","author":"Jacobs","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","article-title":"A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Stem Cell."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2666-5247(20)30004-5","article-title":"Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: An observational study","volume":"1","author":"Chu","year":"2020","journal-title":"Lancet Microbe"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","article-title":"SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19","volume":"73","author":"Wang","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jhep.2020.05.035","article-title":"SARS-CoV-2: Is the liver merely a bystander to severe disease?","volume":"73","author":"Bangash","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jhep.2020.12.007","article-title":"Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD","volume":"74","author":"Meijnikman","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1136\/gut.2004.062398","article-title":"Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin-converting enzyme 2","volume":"54","author":"Paizis","year":"2005","journal-title":"Gut"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1042\/CS20201268","article-title":"ACE2: From the protection of liver disease to the propagation of COVID-19","volume":"134","author":"Warner","year":"2020","journal-title":"Clin. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/hep.31857","article-title":"Functional characterization of organoids from the irreversibly damaged liver of patients with NASH","volume":"74","author":"McCarron","year":"2021","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1111\/j.1750-2659.2011.00287.x","article-title":"Liver involvement during influenza infection: Prospective on the 2009 influenza pandemic","volume":"6","author":"Papic","year":"2012","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"100258","DOI":"10.1016\/j.jhepr.2021.100258","article-title":"Abnormal liver tests in patients with SARS-CoV-2 and influenza-prognostic similarities and temporal disparities","volume":"3","author":"Shafran","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41569-020-00469-1","article-title":"Thrombocytopathy and endotheliopathy: Crucial contributors to COVID-19 thromboinflammation","volume":"18","author":"Gu","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jhep.2021.04.050","article-title":"Liver injury in COVID-19 and IL-6 trans-signaling-induced enthoeliopathy","volume":"75","author":"McConnell","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/liv.14601","article-title":"Liver histopathology in severe COVID-19 respiratory failure is suggestive of vascular alterations","volume":"40","author":"Sonzogni","year":"2020","journal-title":"Liver Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/infdis\/jiaa578","article-title":"Postmortem findings in Italian patients with COVID-19: A descriptive full autopsy study of cases with and without comorbidities","volume":"222","author":"Falasca","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"100434","DOI":"10.1016\/j.eclinm.2020.100434","article-title":"Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series","volume":"24","author":"Rapkiewicz","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jhep.2021.07.008","article-title":"Unraveling the role of liver sinusoidal endothelial cells in COVID-19 liver injury","volume":"75","author":"Saviano","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_66","first-page":"575","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: Evidence from a single-center, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/ajcp\/aqab009","article-title":"Liver pathology and SARS-CoV-2 detection in formalin-fixed tissue of patients with COVID-19","volume":"155","author":"Chornenkyy","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Eng. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"REMAP-CAP Investigators, Gordon, A.C., Mouncey, P.R., Al-Beidh, F., Rowan, K.M., Nichol, A.D., Arabi, Y.M., Annane, D., Beane, A., and van Bentum-Puijk, W. (2021). Interleukin-6 receptor antagonists in critically ill patients with COVID-19. N. Engl. J. Med., 384, 1491\u20131502.","DOI":"10.1056\/NEJMoa2100433"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: From physiopathology to therapy","volume":"64","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in the increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease","volume":"112","author":"Nishimoto","year":"2008","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Patra, T., Meyer, K., Geerling, L., Isbell, T.S., Hoft, D.F., Brien, J., Pinto, A.K., Ray, R.B., and Ray, R. (2020). SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling on epithelial cells. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1009128"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10739680802350104","article-title":"Neutrophil adhesion and activation under flow","volume":"16","author":"Zarbock","year":"2009","journal-title":"Microcirculation"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1038\/s41375-021-01266-6","article-title":"JAK-inhibitors for coronavirus disease-2019 (COVID-19): A meta-analysis","volume":"35","author":"Chen","year":"2021","journal-title":"Leukemia"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41577-020-0305-6","article-title":"In the eye of the COVID-19 cytokine storm","volume":"20","author":"Vaninov","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0304-7","article-title":"Fighting COVID-19 exhausts T cells","volume":"20","author":"Moon","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"eabg5021","DOI":"10.1126\/sciimmunol.abg5021","article-title":"Integrated longitudinal immunotherapeutic, transcriptional, and repertoire analysis delineate immune responses in COVID-19 patients","volume":"6","author":"Notarbartolo","year":"2021","journal-title":"Sci. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.180.4.1273","article-title":"Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection","volume":"180","author":"Graham","year":"1994","journal-title":"J. Exp. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.cell.2020.10.037","article-title":"Multomics resolves a sharp disease-state shift between mild and moderate COVID-19","volume":"183","author":"Su","year":"2020","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analysis reveals immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41392-021-00575-7","article-title":"RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-\u03baB hyper-activation and inflammation","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Trnsduct. Target Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"102560","DOI":"10.1016\/j.jaut.2020.102560","article-title":"Complement activation and endothelial perturbation parallel COVID-19 severity and activity","volume":"116","author":"Cugno","year":"2021","journal-title":"J. Autoimmun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"761816","DOI":"10.3389\/fimmu.2021.761816","article-title":"IgA complexes induce neutrophil extracellular trap formation more potently than IgG complexes","volume":"12","author":"Gimpel","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e2101497118","DOI":"10.1073\/pnas.2101497118","article-title":"IgA potentiates NETosis in response to viral infection","volume":"118","author":"Stacey","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: Immunopathology in COVID-19","volume":"72","author":"Henderson","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19, and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1038\/s41467-021-25509-3","article-title":"New onset IgG autoantibodies in hospitalized patients with COVID-19","volume":"12","author":"Chang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3748\/wjg.v29.i12.1838","article-title":"Autoimmune liver diseases and SARS-CoV-2","volume":"29","author":"Sgamato","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"155873","DOI":"10.1016\/j.cyto.2022.155873","article-title":"SARS-CoV-2 triggering autoimmune diseases","volume":"154","author":"Mobasheri","year":"2022","journal-title":"Cytokine"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"10259","DOI":"10.1016\/j.autrev.2020.102591","article-title":"Molecular mimicry may explain multi-organ damage in COVID-19","volume":"19","author":"Angileri","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_92","first-page":"737","article-title":"Human molecular chaperones share with SARS-CoV-2 antigenic epitopes capable of eliciting autoimmunity against endothelial cells: Possible role of molecular mimicry in COVID-19","volume":"28","author":"Fucarino","year":"2020","journal-title":"Cell Stress Chaperones"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respirat. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1035073","DOI":"10.3389\/fimmu.2022.1035073","article-title":"Autoimmune hepatitis after COVID-19 vaccination","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Efficacy and safety of the mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: Modes of immune activation and future challenges","volume":"21","author":"Teijero","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.31797","article-title":"Outcome of COVID-19 in Patients with Autoimmune Hepatitis: An International Multicenter Study","volume":"73","author":"Efe","year":"2021","journal-title":"Hepatology"},{"key":"ref_100","first-page":"8409269","article-title":"De novo Autoimmune Hepatitis after COVID-19 Infection in an Unvaccinated Patient","volume":"12","author":"Durazo","year":"2022","journal-title":"Case Rep. Hepatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?","volume":"75","author":"Bril","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"108721","DOI":"10.1016\/j.clim.2021.108721","article-title":"COVID-19 vaccine, and autoimmunity: Awakening the sleeping drogan","volume":"226","author":"Akinosoglou","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jhep.2021.06.004","article-title":"Another case of autoimmune hepatitis after SARS-CoV-2 vaccination-still casualty","volume":"75","author":"Londono","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2021.09.031","article-title":"Immone-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed","volume":"76","author":"Gleeson","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.15916","article-title":"Systematic review with meta-analysis: Liver manifestations and outcomes in COVID-19","volume":"52","author":"Kulkarni","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_106","first-page":"687","article-title":"Fatal liver failure after corticosteroid treatment of a hepatitis B carrier","volume":"124","author":"Hammond","year":"1999","journal-title":"Desch. Med. Microbe"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1034\/j.1600-0676.2000.020005415.x","article-title":"Severe exacerbation of hepatitis after short-term corticosteroid therapy in patients with \u201clatent\u201d chronic hepatitis B","volume":"20","author":"Shiota","year":"2000","journal-title":"Liver"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of COVID-19-Final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Eng. J. Med."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Brandi, N., Spinelli, D., Granito, A., Tovoli, F., Piscaglia, F., Golfieri, R., and Renzulli, M. (2023). COVID-19: Has the liver Been Spared?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021091"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jhep.2018.11.015","article-title":"Influenza virus infection is the precipitating event of acute-on-chronic liver failure","volume":"70","author":"Ciesek","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2020.05.013","article-title":"High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry","volume":"73","author":"Moon","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2020.09.024","article-title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study","volume":"74","author":"Marjot","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1053\/j.gastro.2020.04.064","article-title":"Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: A multicenter research network study","volume":"159","author":"Singh","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12072-020-10072-8","article-title":"Pre-existing liver disease is associated with poor outcomes in patients with SARS-CoV-2 infection; The APCOLIS Study (APASL, COVID-19 liver Injury Spectrum Study)","volume":"14","author":"Sarin","year":"2020","journal-title":"Hepatol. Intern."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.31649","article-title":"Cirrhosis and severe acute respiratory syndrome coronavirus 2 infections in US veterans: Risk of infection, hospitalization, ventilation, and mortality","volume":"74","author":"Ioannou","year":"2021","journal-title":"Hepatology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41577-021-00588-x","article-title":"Inflammasome activation of the crux of severe COVID-19","volume":"21","author":"Vora","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in liver diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_119","first-page":"153628","article-title":"SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis, and cytokine release","volume":"3","author":"Junqueira","year":"2021","journal-title":"Res. Sq."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S2468-1253(20)30126-6","article-title":"Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: A systematic review and meta-analysis","volume":"5","author":"Mao","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1111\/liv.14583","article-title":"Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicenter United States experience","volume":"40","author":"Hashemi","year":"2020","journal-title":"Liver Int."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2020.03.044","article-title":"Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study","volume":"73","author":"Ji","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2020.04.027","article-title":"Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis","volume":"73","author":"Zhou","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jhep.2020.09.027","article-title":"Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points","volume":"74","author":"Fondevila","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/hep.31890","article-title":"Current and past infections of HBV do not increase mortality in patients with COVID-19","volume":"74","author":"Yip","year":"2021","journal-title":"Hepatology"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Kang, S.H., Cho, D.-H., Choi, J., Balk, S.K., Gwon, J.G., and Kim, M.Y. (2021). Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0258229"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jhep.2020.07.007","article-title":"SARS-CoV-2 in patients with on antiviral HBV and HCV therapy in Spain","volume":"73","author":"Lens","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/liv.14804","article-title":"Mortality is not increased in SARS-CoV-2 infected persons with hepatitis C virus infection","volume":"41","author":"But","year":"2021","journal-title":"Liver Int."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.12998\/wjcc.v9.i29.8749","article-title":"Chronic hepatitis c infection in COVID-19 patients is associated with increased hospital mortality","volume":"9","author":"Ronderos","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Cerbu, B., Pantea, S., Bratosin, F., Vidican, I., Turaiche, M., Frent, S., Borsi, E., and Marincu, I. (2021). Liver impairment and hematological changes in patients with chronic hepatitis C and COVID-19: A retrospective study after one year of pandemic. Medicina, 57.","DOI":"10.3390\/medicina57060597"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2020.07.040","article-title":"Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients","volume":"74","author":"Calmenero","year":"2021","journal-title":"J. Heaptol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S2468-1253(20)30116-3","article-title":"COVID-19 long-term liver transplant patients: Preliminary experience from an Italian transplant center in Lombardy","volume":"5","author":"Bhoori","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cgh.2020.09.027","article-title":"Predictors and outcomes of COVID-19 in patients with chronic liver disease: US multicenter study","volume":"18","author":"Kim","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/6\/1287\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:45:35Z","timestamp":1760125535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/6\/1287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":133,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["v15061287"],"URL":"https:\/\/doi.org\/10.3390\/v15061287","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]}}}